Fig 3 shows the EML4-ALK fusion gene sequencing and the CT images of the patient with partial response. The tumor shrank from 2.4 to 1.5 cm (36%) after 6 months of TKI treatment (Fig 3B and 3C). The gene discussed is EML4; the disease is neoplasm.